Literature DB >> 23401398

Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Rosalyn J Singleton1, Patricia C Valery, Peter Morris, Catherine A Byrnes, Keith Grimwood, Gregory Redding, Paul J Torzillo, Gabrielle McCallum, Lori Chikoyak, Charmaine Mobberly, Robert C Holman, Anne B Chang.   

Abstract

OBJECTIVE: Indigenous children in developed countries are at increased risk of chronic suppurative lung disease (CSLD), including bronchiectasis. We evaluated sociodemographic and medical factors in indigenous children with CSLD/bronchiectasis from Australia, United States (US), and New Zealand (NZ).
METHODS: Indigenous children aged 0.5-8 years with CSLD/bronchiectasis were enrolled from specialist clinics in Australia (n = 97), Alaska (n = 41), and NZ (n = 42) during 2004-2009, and followed for 1-5 years. Research staff administered standardized parent interviews, reviewed medical histories and performed physical examinations at enrollment.
RESULTS: Study children in all three countries had poor housing and sociodemographic circumstances at enrollment. Except for increased household crowding, most poverty indices in study participants were similar to those reported for their respective local indigenous populations. However, compared to their local indigenous populations, study children were more often born prematurely and had both an increased frequency and earlier onset of acute lower respiratory infections (ALRIs). Most (95%) study participants had prior ALRI hospitalizations and 77% reported a chronic cough in the past year. Significant differences (wheeze, ear disease and plumbed water) between countries were present. DISCUSSION: Indigenous children with CSLD/bronchiectasis from three developed countries experience significant disparities in poverty indices in common with their respective indigenous population; however, household crowding, prematurity and early ALRIs were more common in study children than their local indigenous population. Addressing equity, especially by preventing prematurity and ALRIs, should reduce risk of CSLD/bronchiectasis in indigenous children.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  bronchiectasis; chronic suppurative lung diseases; indigenous population; pneumonia

Mesh:

Year:  2013        PMID: 23401398     DOI: 10.1002/ppul.22763

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  31 in total

1.  Eighteen Years of Respiratory Syncytial Virus Surveillance: Changes in Seasonality and Hospitalization Rates in Southwestern Alaska Native Children.

Authors:  Dana J T Bruden; Rosalyn Singleton; Carolyn S Hawk; Lisa R Bulkow; Stephen Bentley; Larry J Anderson; Leslie Herrmann; Lori Chikoyak; Thomas W Hennessy
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 2.129

2.  Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis.

Authors:  Gregory J Redding; Rosalyn J Singleton; Patricia C Valery; Hayley Williams; Keith Grimwood; Peter S Morris; Paul J Torzillo; Gabrielle B McCallum; Lori Chikoyak; Robert C Holman; Anne B Chang
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

3.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

Review 4.  Improving the Diagnosis, Management, and Outcomes of Children with Pneumonia: Where are the Gaps?

Authors:  Anne B Chang; Mong H Ooi; David Perera; Keith Grimwood
Journal:  Front Pediatr       Date:  2013-10-23       Impact factor: 3.418

5.  Food insecurity, vitamin D insufficiency and respiratory infections among Inuit children.

Authors:  Sze Man Tse; Hope Weiler; Tom Kovesi
Journal:  Int J Circumpolar Health       Date:  2016-02-15       Impact factor: 1.228

6.  Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis.

Authors:  G Hodge; J W Upham; A B Chang; K J Baines; S T Yerkovich; S J Pizzutto; S Hodge
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

7.  Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Keith Grimwood; Carolyn Maclennan; Andrew V White; Mark D Chatfield; Theo P Sloots; Ian M Mackay; Heidi Smith-Vaughan; Clare C McKay; Lesley A Versteegh; Nerida Jacobsen; Charmaine Mobberley; Catherine A Byrnes; Anne B Chang
Journal:  Front Pediatr       Date:  2015-04-21       Impact factor: 3.418

8.  A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Mark D Chatfield; Carolyn Maclennan; Andrew V White; Theo P Sloots; Ian M Mackay; Anne B Chang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

9.  Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis.

Authors:  Kim M Hare; Rosalyn J Singleton; Keith Grimwood; Patricia C Valery; Allen C Cheng; Peter S Morris; Amanda J Leach; Heidi C Smith-Vaughan; Mark Chatfield; Greg Redding; Alisa L Reasonover; Gabrielle B McCallum; Lori Chikoyak; Malcolm I McDonald; Ngiare Brown; Paul J Torzillo; Anne B Chang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 10.  Respiratory risks from household air pollution in low and middle income countries.

Authors:  Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin
Journal:  Lancet Respir Med       Date:  2014-09-02       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.